Skip to main content
Not Found
Digital Seminar

Antibiotic Selection for the Geriatric Population


Speaker:
Eric Wombwell, PharmD, BCIDP
Duration:
3 Hours 19 Minutes
Language:
Presented in EN, subtitles in EN and FR, handouts in EN
Format:
Audio and Video
Copyright:
Aug 18, 2022
Product Code:
POS078469


Description

It’s challenging to stay current on the evolving best treatments for c.difficile, community-acquired pneumonia and urinary tract infections. This session will also deliver an evidence-based assessment of penicillin allergies in the geriatric population. Eric Wombwell, PharmD, BCIDP, a board-certified infectious diseases pharmacist, will deliver the very latest updates so you can confidently choose the most effective medications for your older patients, while also considering the importance of minimizing adverse risks.

Credit

Program Information

Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.



Canada Credit - *

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your licensing board's rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.

 


Canada Credit - ---

Earn up to 3.25 CE hours. Please see below, for more details, as credit amounts vary by jurisdiction and profession. 


Canada Credit - Other Professions

This self-study activity qualifies for 3.25 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.


US National Boards - Nurses, Nurse Practitioners, and Clinical Nurse Specialists – ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 3.25 contact hours. Expires: 08/20/2025.



Handouts

Speaker

Eric Wombwell, PharmD, BCIDP's Profile

Eric Wombwell, PharmD, BCIDP Related seminars and products


Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.

Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.

 

Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Questions?

Visit our FAQ page at https://www.pesicanada.ca/faq or contact us at https://www.pesicanada.ca/contact-us.


Objectives

  1. Evaluate beta-lactam reaction histories to make evidence-based decisions on the need to avoid beta-lactam therapies.
  2. Formulate effective care plans that limit risk for Clostridioides difficile infections.
  3. Select anti-infectives to treat Clostridioides difficile that reduce the risk for recurrent infections.
  4. Develop risk factor–based empiric antibiotic regimens for patients with suspected community-acquired pneumonia.
  5. Design safe and effective care plans for urinary tract infections.
  6. Choose effective antibiotic therapies that minimize risk for adverse effects in the geriatric population.

Outline

Penicillin Allergy
  • Side Effect vs. Allergy
  • Reassessing Allergy Statistics
  • Cephalosporin Cross-sensitivity
C. difficile Infections
  • Vancomycin vs. Fidaxomicin
  • Managing Recurrence
  • Probiotic Assessment
Community Acquired Pneumonia
  • Assess 2019 ATS/IDSA Guidelines
  • Streptococcus pneumonia Resistance
  • Evaluate and Contrast Oral Therapies for CAP
Urinary Tract Infections
  • E.coli Resistance
  • Efficacy and safety considerations antibiotics
  • Considerations for recurrent UTI

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Physicians
  • Physical Therapists
  • Occupational Therapists
  • Speech Language Pathologists
  • Nursing Home Administrators

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesicanada.com.

Please wait ...

Back to Top